Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Operations (2020 - 2025)

Biofrontera (BFRI) has 6 years of Cash from Operations data on record, last reported at 3800000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations fell 202.79% year-over-year to 3800000.0; the TTM value through Sep 2025 reached 12000000.0, up 33.94%, while the annual FY2024 figure was 10300000.0, 58.63% up from the prior year.
  • Cash from Operations reached 3800000.0 in Q3 2025 per BFRI's latest filing, down from 3100000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 125000.0 in Q2 2022 and bottomed at 21015000.0 in Q4 2021.
  • Average Cash from Operations over 5 years is 4689947.37, with a median of 3400000.0 recorded in 2021.
  • Peak YoY movement for Cash from Operations: skyrocketed 111.36% in 2022, then tumbled 8348.8% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 21015000.0 in 2021, then skyrocketed by 60.64% to 8271000.0 in 2022, then decreased by 7.19% to 8866000.0 in 2023, then surged by 88.72% to 1000000.0 in 2024, then tumbled by 280.0% to 3800000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 3800000.0 in Q3 2025, 3100000.0 in Q2 2025, and 4100000.0 in Q1 2025.